City
Epaper

Two indigenous candidate COVID-19 vaccines get DCGI nod to start early phase human trials

By ANI | Updated: July 14, 2020 19:35 IST

Two indigenous candidate vaccines for COVID-19 have got DCGI clearance to start early phase human trials in the country, the Indian Council of Medical Research (ICMR) said on Tuesday.

Open in App

Two indigenous candidate vaccines for COVID-19 have got DCGI clearance to start early phase human trials in the country, the Indian Council of Medical Research (ICMR) said on Tuesday.

"There are two Indian indigenous candidate vaccines. They have undergone successful toxicity studies in rats, mice and rabbits. The data was submitted to DCGI following which both these got clearance to start early phase human trials early this month," said Dr Balram Bhargava, DG-ICMR at a daily press briefing here.

"They have got their sites ready and they are doing their clinical study on approximately a thousand volunteers each at different sites," he added.

Bhargava said that experiments for the two vaccines, among others, are also being done at NIV, Pune and spoke about the various programmes being carried out to develop a vaccine globally.

"Recently, Russia has fast-tracked a vaccine which has been successful in the early phases and they have fast-tracked its development. The whole world has applauded it and congratulated Russia. China has also fast-tracked its vaccine programme and fast-tracked its studies with vaccines. The US has again fast-tracked two of its vaccine candidates and the UK is also looking at how it can fastrack the Oxford vaccine candidate," Bhargava said.

He added that India supplies over 60 per cent of the vaccines for various diseases to countries around the world and said that it makes India's role a key one in the race to prepare and supply a COVID-19 vaccine to the world.

"India is considered as the pharmacy of the world. 60 per cent of the drugs utilised in the US are of Indian origin. The other fact which is not well known is that 60 percent of vaccines supplied around the world are of Indian origin, so India is perceived and is well known for vaccine supply in the world," Bhargava said.

"Any vaccine produced in any party part of the world will ultimately have to be scaled up by India or by China. Because these are the two major vaccine producers of the world. Everyone who is trying to prepare a vaccine is in talks with India," he further said.

( With inputs from ANI )

Tags: puneOxfordIndian Council Of Medical ResearchIcmrBalram BhargavaIndia council of medical researchIndian council of medicalIndian council medical researchIndian council for medicalMumbai pune
Open in App

Related Stories

PunePune: Ajit Pawar Meet Families of Tourists Killed in Pahalgam Terrorist Attack (Watch Video)

PuneGBS Scare in Pune: 15-Year-Old Baramati Boy Admitted to ICU With Suspected Guillain-Barré Syndrome

Pune8-Month-Old Baby Kidnapped at Pune Railway Station, Rescued After 27-Day Police Operation

PunePune: Truck Falls Into 200-Feet Gorge Near Katraj Tunnel, Trapped Driver Rescued by Fire Brigade

PunePahalgam Terror Attack: Victim Jagdale’s Family in Pune Urges Sharad Pawar to Raise Issue in Parliament

National Realted Stories

NationalBengaluru Namma Metro Update: Services to Start Early on Sunday for TCS World 10K Run; Check Timings & Other Details

NationalIllegal coal mining: ED conducts raids in Assam, Meghalaya under PMLA

National'Atmosphere has changed': BSF's vigil sharpens after Pahalgam tragedy

NationalMamata Banerjee announces Rs 10 lakh compensation for families of Pahalgam victims

NationalBuild check dams in hilly terrains to conserve rainwater, says Haryana CM